When will Flurazepam Hydrochloride Capsule be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Flurazepam Hydrochloride Capsule changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Flurazepam Hydrochloride Capsule

Brand names: Flurazepam Hydrochloride

Category: Neurology, Oncology, Other

Unavailable 2Available 4

FDA status: Current · Last FDA update: Sep 15, 2026 · First posted: Aug 3, 2022 (in shortage 4 years 1 month) · 2 manufacturers, 6 listed presentations

As of Sep 15, 2026, the FDA lists Flurazepam Hydrochloride Capsule as currently in shortage. Of 6 manufacturer presentations, 2 Unavailable, 4 Available.

Ask your pharmacist: which of the 2 manufacturers below can they order right now, and whether a different strength or form of Flurazepam Hydrochloride Capsule is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) NDC 0378-4415-01	Rising Pharma Holdings, Inc.	Unavailable	Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) NDC 62135-736-90	Chartwell Molecular Holdings LLC	Available	-
Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) NDC 62135-736-30	Chartwell Molecular Holdings LLC	Available	-
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) NDC 0378-4430-01	Rising Pharma Holdings, Inc.	Unavailable	Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) NDC 62135-737-90	Chartwell Molecular Holdings LLC	Available	-
Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) NDC 62135-737-30	Chartwell Molecular Holdings LLC	Available	-

Related medications in shortage

Other Neurology, Oncology, Other medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Flurazepam Hydrochloride Capsule (FDA data as of Sep 15, 2026). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Flurazepam Hydrochloride Capsule. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Flurazepam Hydrochloride Capsule.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/flurazepam-hydrochloride-capsule.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).